Professor and Chair, Division of Gynecologic Surgery, Obstetrics and Gynecology, Mayo Medical School
Obstetrics & Gynecology
Dr. Sean C. Dowdy, MD
|
|
Give Review
Doctor Sean C. Dowdy, MD is an expert in the field of Obstetrics & Gynecology. He studied medicine at Georgetown University School of Medicine. Georgetown University School of Medicine has a rank of 49 in research and a 84 in primary care He received awards:"Fellow (FACS)". Sean Dowdy is a published doctor as well. He has 97 publications published. The latest was: Molecular classification of high grade endometrioid and clear cell ovarian cancer using TCGA gene expression signatures. He is registered with Medicare and accepts Medicare payments.
Publications
- Comparison of a sentinel lymph node and a selective lymphadenectomy algorithm in patients with endometrioid endometrial Carcinoma and limited myometrial invasion.
- Guidelines for pre- and intra-operative care in gynecologic/oncology surgery: Enhanced Recovery After Surgery (ERAS®) Society recommendations - Part I.
- Incorporating robotic-assisted surgery for endometrial Cancer staging: Analysis of morbidity and costs.
- Guidelines for postoperative care in gynecologic/oncology surgery: Enhanced Recovery After Surgery (ERAS®) Society recommendations - Part II.
- The effect of diabetes and metformin on clinical outcomes is negligible in risk-adjusted endometrial Cancer cohorts.
- Incisional Recurrences After Endometrial Cancer Surgery.
- Quinacrine promotes autophagic cell death and chemosensitivity in ovarian Cancer and attenuates tumor growth.
- Detection of circulating tumor cells in high-risk endometrial Cancer.
- Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian Cancer.
- Characterization of precursor lesions in the endometrium and fallopian tube epithelium of early-stage uterine serous Carcinoma.
- Candidate locus analysis of the TERT-CLPTM1L Cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial Cancer risk.
- Surgical site infection after primary surgery for epithelial ovarian Cancer: Predictors and impact on survival.
- Enhanced Recovery Pathways in Gynecologic Oncology.
- Effect of Tubal Sterilization Technique on Risk of Serous Ovarian and Primary Peritoneal Carcinoma.
- Prognostic and therapeutic relevance of molecular subtypes in high-grade serous ovarian Cancer.
- Lymphedema After Surgery for Endometrial Cancer: Prevalence, Risk Factors, and Quality of Life.
- Short-term outcomes after incontinent conduit for gynecologic Cancer: Comparison of ileal, sigmoid, and transverse colon.
- Risk-scoring models for individualized prediction of overall survival in low-grade and high-grade endometrial Cancer.
- Racial disparities in uterine clear cell Carcinoma: a multi-institution study.
- Role of pelvic and para-aortic lymphadenectomy in endometrial Cancer: Current evidence.
- Improving oncologic outcomes for women with endometrial Cancer: Realigning our sights.
- Efficacy of contemporary chemotherapy in stage IIIC endometrial Cancer: A histologic dichotomy.
- Improving value in gynecologic surgery: we can all do better.
- Prospective assessment of the prevalence of pelvic, paraaortic and high paraaortic lymph node metastasis in endometrial Cancer.
- Risk factors that mitigate the role of paraaortic lymphadenectomy in uterine endometrioid Cancer.
- Evaluating the prognostic significance of preoperative thrombocytosis in epithelial ovarian Cancer.
- Development of an intracellular, DNA Methyltransferase-Specific, and Gene-Specific Assay for Studying Dynamic DNA Methylation.
- Risk-scoring system for the individualized prediction of lymphatic dissemination in patients with endometrioid endometrial Cancer.
- Risk of postoperative venous thromboembolism after minimally invasive surgery for endometrial and Cervical cancer is low: a multi-institutional study.
- Comparative outcomes assessment of uterine grade 3 endometrioid, serous, and clear cell Carcinomas.
- Multiple large bowel resections: Potential risk factor for anastomotic leak.
- Predictors and costs of surgical site infections in patients with endometrial Cancer.
- HE4 (WFDC2) Promotes Tumor Growth in Endometrial Cancer Cell Lines.
- Optimizing patient derived mesenchymal stem cells as virus carriers for a Phase I clinical trial in ovarian Cancer.
- Safety of culdotomy as a surgical approach: implications for natural orifice transluminal endoscopic surgery.
- Impact of tubal ligation on routes of dissemination and overall survival in uterine serous Carcinoma.
- Development and Validation of a Self-Report Lower-Extremity Lymphedema Screening Questionnaire in Women.
- Factors predictive of postoperative morbidity and cost in patients with endometrial Cancer.
- Risk factors for developing endometrial Cancer after benign endometrial sampling.
- Endometrioid endometrial Carcinoma with atrophic endometrium and poor prognosis.
- Preoperative biopsy and intraoperative tumor diameter predict lymph node dissemination in endometrial Cancer.
- Prospective assessment of survival, morbidity, and cost associated with lymphadenectomy in low-risk endometrial Cancer.
- Incidence of and risk factors for postoperative ileus in women undergoing primary staging and debulking for epithelial ovarian Carcinoma.
- The Role of Vaginal Brachytherapy in the Treatment of Surgical Stage I Papillary Serous or Clear Cell Endometrial Cancer.
- Correlation of serum HE4 with tumor size and myometrial invasion in endometrial Cancer.
- Long-Term Outcomes with Intraoperative Radiotherapy as a Component of Treatment for Locally Advanced or Recurrent Uterine Sarcoma.
- Intraoperative Electron Beam Radiotherapy (IOERT) in the Management of Recurrent Ovarian Malignancies.
- The impact of surgical guidelines and periodic quality assessment on the staging of endometrial Cancer.
- Intraoperative Imaging in Ovarian Cancer: Fact or Fiction?
- Lymphadenectomy in endometrial Cancer: which is the right question?
- Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian Cancer.
- Quality improvement in the surgical approach to advanced ovarian Cancer: the Mayo Clinic experience.
- Endometrial stromal sarcoma: treatment and patterns of recurrence.
- Extra-peritoneal laparoscopic para-aortic lymphadenectomy--a prospective cohort study of 293 patients with endometrial Cancer.
- Clear cell Carcinoma of the cervix: a multi-institutional review in the post-DES era.
- Assessment of outcomes and morbidity following diaphragmatic peritonectomy for women with ovarian Carcinoma.
- Claudin-3 and claudin-4 expression in serous papillary, clear-cell, and endometrioid endometrial Cancer.
- Prospective assessment of lymphatic dissemination in endometrial Cancer: a paradigm shift in surgical staging.
- Current issues in the management of endometrial Cancer.
- Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian Cancer.
- Treatment of pulmonary recurrences in patients with endometrial Cancer.
- Role of systematic lymphadenectomy and adjuvant therapy in stage I uterine papillary serous Carcinoma.
- Role of cytoreduction in stage III and IV uterine papillary serous Carcinoma.
- Epigenetic considerations for endometrial Cancer prevention, diagnosis and treatment.
- Histone deacetylase inhibitors induce apoptosis in both Type I and Type II endometrial Cancer cells.
- Analysis of factors impacting operability in stage IV ovarian Cancer: rationale use of a triage system.
- Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian Cancer.
- Histone deacetylase inhibitors and paclitaxel cause synergistic effects on apoptosis and microtubule stabilization in papillary serous endometrial Cancer cells.
- hMLH1 promoter methylation and silencing in primary endometrial Cancers are associated with specific alterations in MBDs occupancy and histone modifications.
- Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial Cancer patients.
- Radical pelvic resection and intraoperative radiation therapy for recurrent endometrial Cancer: technique and analysis of outcomes.
- Surgical treatment of diaphragm disease correlates with improved survival in optimally debulked advanced stage ovarian Cancer.
- Aggressive surgical effort and improved survival in advanced-stage ovarian Cancer.
- Biallelic methylation and silencing of paternally expressed gene 3 (PEG3) in gynecologic Cancer cell lines.
- Epigenetic-mediated upregulation of progesterone receptor B gene in endometrial Cancer cell lines.
- Predictors of vaginal relapse in stage I endometrial Cancer.
- Histone deacetylase inhibitors decrease DNA methyltransferase-3B messenger RNA stability and down-regulate de novo DNA methyltransferase activity in human endometrial ...
- Opposite alterations of DNA methyltransferase gene expression in endometrioid and serous endometrial Cancers.
- Salvage whole-abdominal radiation therapy after second-look laparotomy or secondary debulking surgery in patients with ovarian Cancer.
- Overexpression of the TGF-beta antagonist Smad7 in endometrial Cancer.
- Up-regulation of DNA methyltransferase 3B expression in endometrial Cancers.
- High-risk endometrial Cancer subgroups: candidates for target-based adjuvant therapy.
- Surgical risk reduction: prophylactic salpingo-oophorectomy and prophylactic mastectomy.
- The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian Carcinoma.
- Long-term follow-up of women with ovarian Cancer after positive second-look laparotomy.
- HER2/Neu- and TAK1-mediated up-regulation of the transforming growth factor beta inhibitor Smad7 via the ETS protein ER81.
- Preparing for the unexpected: encountering gynecological problems when operating for colon Cancer.
- Multimodal therapy including neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) for stage IIB to IV Cervical cancer.
- HE4 transcription- and splice variants-specific expression in endometrial Cancer and correlation with patient survival.
- Loss of HSulf-1 promotes altered lipid metabolism in ovarian Cancer.
- DNA hypermethylation as a chemotherapy target.
- New surgical staging of endometrial Cancer: 20 years later.
- Lymphadenectomy in endometrial Cancer: when, not if.
- Referral and ascertainment bias in patients with synchronous and metachronous endometrial malignancy.
- Nonhistone protein acetylation as Cancer therapy targets.
- Molecular classification of high grade endometrioid and clear cell ovarian Cancer using TCGA gene expression signatures.
Schools
Georgetown University School Of Medicine
Mayo Grad School MedMayo Fndn
Procedures Preformed
- Colposcopy
- Destruction or Excision of Lesion of Cervix (incl. LEEP)
- Dilation and Curettage
- Excision of Cervix
- View All
Conditions Treated
- Carcinoma in Situ
- Cervical Cancer
- Cervicitis
- Chronic Pelvic Pain
- View All
Doctors Specialties
- Gynecologic Oncology
- Obstetrics
- Gynecology
Accepted Insurances
Awards
- Fellow (FACS)
Education
-
Mayo School of Graduate Medical Education -
Georgetown University School of Medicine
Hospital
-
Mayo Clinic - Rochester, Minnesota
Drug Facts
| NPI NUMBER | 1134109630 | |
| NPPES Provider LastName | DOWDY | |
| NPPES Provider FirstName | SEAN | |
| NPPES Provider ZIPCode | 559050001 | |
| NPPES Provider State | MN | |
| Specialty Description | Gynecological/Oncology | |
| Total Claim Count | 11.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1134109630 |
| Last Name Of The Provider | DOWDY |
| First Name Of The Provider | SEAN |
| View All |
Similar Doctors
|
|
Dr. C Robert Stanhope, MD |
|
|
Dr. Karl C. Podratz, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William A. Cliby, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Monica B. Jones, MD |
|
|
Dr. Bobbie S. Gostout, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elizabeth A. Baldwin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary L. Marnach, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kenneth M. Palmer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary C. Tolcher, MD
This Doctor is OpenDoctor Recommended.
|